Trial Design Solutions
-
Educate, Engage, Enroll: Accelerating Patient Recruitment
9/21/2023
Built on a globally compliant platform, explore a suite of technologies and services that sits at the crossroads of sponsors, recruitment partners, patients, HCPs, and trial sites.
-
Designed Around Your Needs: Let's Accelerate Enrollment Together
7/15/2025
CSSi offers unmatched depth and breadth in therapeutic expertise, providing full-spectrum, in-house capabilities, positing the organization as a true end-to-end partner in clinical trials.
-
Citeline Connect: The All-In-One Clinical Trial Recruitment Platform
7/18/2022
Citeline Connect is an end-to-end trial education, enrollment and recruiting platform that accelerates study startup, drives engagement, and enables community and communication surrounding clinical trials.
-
Home Trial Support: The Engine Powering DCT
8/10/2021
By conducting trial visits outside of the site, physicians can expand their reach, making drug development more accessible. Read about how MRN's Home Trial Support "HTS" is the engine powering DCTs.
-
PatientSelect : Direct Access To Patients And Their Health Data
5/18/2022
Elligo’s PatientSelect gives you direct access to patients and their health data — reducing enrollment costs and challenges, accelerating study timelines, and putting the focus where it belongs: on patients.
-
Phlexglobal Experts Fill The Gaps In eTMF Management
12/16/2022
Enable busy study teams to assess, prevent, and manage risk across the entire TMF spectrum – improving inspection-readiness with less effort.
-
New Is Risky. Start With A Free Feasibility Report.
7/23/2024
Get a free preliminary evaluation of your protocol design from a leading CRO in Eastern Europe.
-
Lab Alerts: Target Relevant Patients For Clinical Trials
3/15/2024
Get near real-time notifications when a potential trial candidate presents in the clinic, which will help enable recruitment before the window of opportunity closes.
-
Elligo's Customizable Solutions For Sponsors
1/17/2023
With the personalized PatientSelect® and SiteSelect service models and proprietary technology, trials are better equipped to research diagnostics, drugs, biologics, and devices at every phase.
-
GMO Solutions
6/27/2023
Novotech initiated the first national, privately owned, commercial Institutional Biosafety Committee (IBC) in Australia, successfully accredited by the Australian Office of the Gene Technology Regulator (OGTR).